At Affimed, we are committed to improving outcomes for patients with cancer. Our scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unique approach to fighting cancer. With our unparalleled expertise in innate immunity and innate cell engager-based medicines, we aim to overcome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
Where are Affimed’s corporate headquarters?
Affimed’s headquarters are located at Technologiepark, Im Neuenheimer Feld 582, 69120 Heidelberg, Germany.
When was the company founded?
Affimed was founded in 2000.
Where is the company incorporated?
Affimed N.V. is incorporated under the laws of the Netherlands.
When did Affimed go public?
Affimed’s common shares began trading on September 12, 2014.
When is Affimed’s fiscal year-end?
Affimed’s fiscal year ends on December 31 of each year.
Affimed’s fiscal quarters end on March 31, June 30, September 30 and December 31 of each year.
How is Affimed stock traded?
Affimed’s common shares are listed on the NASDAQ Global Market under the symbol AFMD.
Who is Affimed’s transfer agent?
American Stock Transfer and Trust Company LLC.
Who are Affimed’s independent auditors?
KPMG AG Wirtschaftsprüfungsgesellschaft Mannheim
Address: Schlossgartenstraße 1, 68161 Mannheim
P.O. Box: Postfach 10 07 43, 68007 Mannheim
Phone: +49 621 4267-0
Where can I get the latest corporate news releases and financial reports?
Affimed’s press release archives can be viewed at: News.
Affimed’s financial reports are available at: SEC & Financial Reports.
Find out more about Affimed quotes and general Share Information, Chart, Stock, the Historical Price – and our Investment Calculator.
Find out more about the SEC & Financial Reports in our list that represents all Affimed SEC filings and financial reports.
The Supervisory Board of Affimed sets high standards for the Company’s employees, officers and directors including standards for sound corporate governance.